Global Rank
Daily Visitors
Last scanned
Domain Age
Updated:
COSENTYX® (secukinumab) | Home Page
Learn more about COSENTYX® (secukinumab), a treatment option for PsO, HS, PsA, AS, nr-axSpA, pediatric PsO, and pediatric JIA. See full prescribing and safety information.
This website is hosted with CloudFlare, Inc., which reserves the following IP addresses for cosentyx.com: 104.18.32.21, 172.64.155.235. Moreover, DNS used with this website include a1-254.akam.net, a2-66.akam.net, a24-65.akam.net, a28-67.akam.net, a7-64.akam.net, a9-65.akam.net, dns1.novartis.com, dns2.novartis.com, dns3.novartis.com, dns4.novartis.com. Subnet identifier ranges from 104.16.0.0 to 104.31.255.255. Classless Inter-Domain Routing (CIDR) is 104.16.0.0/12. ARIN net type is Direct Allocation.
Global Rank
Daily Visitors
Last scanned
Domain Age
CloudFlare, Inc.
a1-254.akam.net
a2-66.akam.net
a24-65.akam.net
a28-67.akam.net
a7-64.akam.net
a9-65.akam.net
dns1.novartis.com
dns2.novartis.com
dns3.novartis.com
dns4.novartis.com
{{value}}
2012-11-06
2024-11-06
MarkMonitor Inc.
{{value}}
The registrar of cosentyx.com is MarkMonitor Inc. and the name expires on 2024-11-06. According to open source data, you can reach the owner at novartis.domains@markmonitor.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Switzerland, Swiss Confederation.
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
267